Alpha-1 Antitrypsin Deficiency: Symptoms, Treatments and Key Companies in the Market
Apr 12, 2021
Alpha1-antitrypsin deficiency (AATD) was first identified by Carl-Bertil Laurell and Sten Eriksson (Laurell and Eriksson 1963) in 1963, who discovered a link between ...
Read More
Limited Therapeutics Options and A Weak Pipeline: What Lies Ahead in the Cancer Anorexia Market?
Apr 9, 2021
Eating food is the most regular habit a person divulges into without realizing its importance. Consumption of food, although linked with gaining necessary nutrients, vitami...
Read More
Artios collaborates with Novartis; Scholar Rock eyes Phase III trial; Novavax starts crossover arms in Covid-19 trials; Volastra nabs $44M
Apr 8, 2021
Artios Pharma announces collaboration with Novartis to tap next-generation DDR cancer therapies Artios Pharma Limited, a leading DNA Damage Response (DDR) company exploitin...
Read More
E-Pharmacies: A Disruptive Innovation and the Future of Pharma Sector
Apr 7, 2021
Over the past few, the internet and communication technology (ICT) has evolved significantly and empowered the consumer like never before. Today, the consumer has thousands...
Read More
Cidara Therapeutics and J&J’s USD 780M Deal; FDA’s Approval to Supernus’s ADHD drug; Rain Therapeutics USD 100M IPO; NMPA Approval to Antengene’s ATG-019 IND Application
Apr 6, 2021
Cidara Therapeutics Inks USD 780M Deal with J&J The share price of Cidara observed a sudden jump after the news of the collaboration of the company with J&J came. C...
Read More
Kinase Inhibitors: Challenging the established Biologics as the new standard of care in autoimmune diseases?
Apr 5, 2021
Autoimmune and inflammatory diseases are common with a diverse array. Different organs are affected, and significant variability is seen among the individuals when tal...
Read More
A New Addition to Existing Chimeric Antigen Receptor Therapies –Potential for a Game Changer in Blood Cancers
Apr 2, 2021
Chimeric Antigen Receptor (CAR) Therapies have changed the treatment paradigm of hematological malignancies to a vast extent. These personalized therapies have not only evo...
Read More
Amgen to acquire Rodeo for $55M; Novartis expands radioligand portfolio; Organon acquires Alydia for $240M; Forma announces positive FT-4202 dose levels
Apr 1, 2021
Amgen to acquire Rodeo Therapeutics for USD 55 Million Upfront Amgen Inc. and Rodeo Therapeutics Corporation announced a deal under which Amgen will take over Rodeo, ...
Read More
How Depression Is Eroding The Mental And The Physical Health Of The Society?
Mar 31, 2021
Depression is a global health burden and continues to increase with each passing day. As per the WHO, globally, more than 264 million people of all ages suffer from depress...
Read More
Bright Peak, Ajinomoto to Create Novel Immunocytokines; FDA’s Rejection to Lilly/Pfizer’s Tanezumab for Osteoarthritis Pain; Ikena Oncology Unveils IPO Pricing
Mar 30, 2021
Bright Peak Therapeutics, Ajinomoto Collaborates to Create Novel Immunocytokines Bright Peak Therapeutics has announced a research and licensing collaboration with Ajinomot...
Read More
Ever-Evolving Market Landscape of Transcatheter Aortic Valve Replacement
Mar 29, 2021
Transcatheter Aortic Valve Replacement (TAVR), also known as Transcatheter Aortic Valve Implantation (TAVI), is a minimally invasive surgery performed to insert a new valve...
Read More
How Will New Discoveries of Deep Brain Stimulation Devices Transform the Pharma Domain?
Mar 26, 2021
Deep brain stimulation (DBS) is a surgical procedure that requires the implantation of a device capable of sending electrical impulses to the brain areas responsible for bo...
Read More
Asher Bio raises $55M; Roche halts Huntington’s phase 3 trial; Novartis’ radioligand hits goal in phase 3; EpimAb raises $120M in Series C
Mar 25, 2021
Asher Bio raises USD 55 Million in Series A financing Asher Biotherapeutics, a biotechnology company developing exactly targeted immunotherapies for cancer and other diseas...
Read More
How Fitness Trackers Are Shaping the Future of Healthcare?
Mar 24, 2021
Over the past few years, technology has led to the development of many innovative and effective fitness gadgets that have significantly improved the quality of lives. Wheth...
Read More
Evotec, Takeda Deal; AZ COVID Vaccine US Trials; Promega’s Recognition; Roche’s Tecentriq Results in NSCLC
Mar 23, 2021
Promega Biotech Ibérica Gains Recognition for COVID-19 Response in Spain Promega Biotech Ibérica has been heralded as the business leader in Spain for its COVID-19 respon...
Read More
